Home
/
Annovis Bio, Inc.
/
Financials
/
Quarterly
Annovis Bio, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Annovis Bio, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$0
Nov 12, 2025
Q2
2025
Jun 30, 2025
$0
Aug 12, 2025
Q1
2025
Mar 31, 2025
$0
May 13, 2025
Q3
2024
Sep 30, 2024
$0
Nov 8, 2024
Q2
2024
Jun 30, 2024
$0
Aug 14, 2024
Q1
2024
Mar 31, 2024
$0
May 10, 2024
Q3
2023
Sep 30, 2023
$0
Nov 8, 2023
Q2
2023
Jun 30, 2023
$0
Aug 14, 2023
Q1
2023
Mar 31, 2023
$0
May 10, 2023
Q3
2022
Sep 30, 2022
$0
Nov 8, 2022
Q2
2022
Jun 30, 2022
$0
Aug 8, 2022
Q1
2022
Mar 31, 2022
$0
May 4, 2022
Q3
2021
Sep 30, 2021
$0
Nov 3, 2021
Q2
2021
Jun 30, 2021
$0
Jul 28, 2021
Q1
2021
Mar 31, 2021
$0
May 6, 2021
Q3
2020
Sep 30, 2020
$0
Nov 4, 2020
Q2
2020
Jun 30, 2020
$0
Jul 29, 2020
Q1
2020
Mar 31, 2020
$0
May 5, 2020
Q1
2020
Dec 31, 2019
$0
May 5, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.26M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($6.22M)
Aug 12, 2025
Q3
2025
Jun 30, 2025
($6.22M)
Nov 12, 2025
Q2
2025
Mar 31, 2025
($5.54M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($5.54M)
May 13, 2025
Q3
2025
Mar 31, 2025
($5.54M)
Nov 12, 2025
Q3
2025
Sep 30, 2024
($12.64M)
Nov 12, 2025
Q3
2025
Jun 30, 2024
($5.02M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($5.02M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($1.07M)
May 13, 2025
Q3
2025
Mar 31, 2024
($1.07M)
Nov 12, 2025
Q2
2025
Mar 31, 2024
($1.07M)
Aug 12, 2025
Q3
2024
Sep 30, 2023
($14.72M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($9.54M)
Aug 14, 2024
Q3
2024
Jun 30, 2023
($9.54M)
Nov 8, 2024
Q3
2024
Mar 31, 2023
($9.74M)
Nov 8, 2024
Q2
2024
Mar 31, 2023
($9.74M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($9.74M)
May 10, 2024
Q3
2023
Sep 30, 2022
($6.43M)
Nov 8, 2023
Q3
2023
Jun 30, 2022
($5.94M)
Nov 8, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.43M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($6.27M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($6.28M)
May 13, 2025
Q3
2025
Sep 30, 2024
($4.39M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($7.76M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($7.81M)
May 13, 2025
Q3
2024
Sep 30, 2023
($14.86M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($9.76M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($9.97M)
May 10, 2024
Q3
2023
Sep 30, 2022
($6.48M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($5.97M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($5.25M)
May 10, 2023
Q3
2022
Sep 30, 2021
($2.85M)
Nov 8, 2022
Q2
2022
Jun 30, 2021
($2.53M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($3.23M)
May 4, 2022
Q3
2021
Sep 30, 2020
($1.60M)
Nov 3, 2021
Q2
2021
Jun 30, 2020
($2.54M)
Jul 28, 2021
Q1
2021
Mar 31, 2020
($583.2K)
May 6, 2021
Q3
2020
Sep 30, 2019
($241.8K)
Nov 4, 2020
Q2
2020
Jun 30, 2019
($306.1K)
Jul 29, 2020